ECRIN (European Clinical Research Infrastructure Network)

We are very excited to announce the launch of our International Clinical Trials Day (ICTD) for 2025. We are co-hosting with our Spanish partner Spanish Clinical Research Network (SCReN) to bring you what we hope to be a very insightful day. 📆Date: Tuesday, 20 May, 2025 📍 Place: Madrid, Spain 👩🔬 Theme: Rethinking Clinical Trials: Inclusivity in Practice The need for greater inclusivity in clinical trials is clear in Europe and there is an increasing obligation to progress from discussion to concrete implementation. By uniting different stakeholders from the community, ICTD will shed light not only on why diversity, equity and inclusion should be embraced in clinical research but will give concrete examples of what has been done so far and where there are still hurdles to overcome. More information will be released soon. For now, please mark the date in your diaries. We hope you are able to join us! 🌟 https://lnkd.in/e_mfQNxM #ClinicalTrials #DEI #ICTD #ICTD2025 CZECRIN, Infrastructure F-CRIN, KKS-Netzwerk e. V., HRB National Clinical Trials Office (NCTO), HECRIN (Hungarian National Health Research Agency) GreCRIN _ECRIN, ItaCRIN (Istituto Superiore di Sanità), NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, Spanish Clinical Research Network (SCReN), SLOVACRIN, Swiss Clinical Trial Organisation

In 2024, we developped our Gender Equality Plan (GEP) in alignment with European Commission guidelines. 📖 This plan reflects our ongoing commitment to fostering equal opportunities and fair treatment at every stage of professional life. 🙌 This second GEP edition builds on insights from our workforce analysis and a dedicated working group comprising volunteer employees, HR, and the Head of Operations. It outlines an action plan addressing five key areas: ✔️ Work-life balance and organisational culture ✔️ Gender balance in leadership and decision-making ✔️ Equality in recruitment and career progression ✔️ Integration of gender perspectives into research content ✔️ Prevention of gender-based violence, including sexual harassment We are already working on the 2025 edition, striving to go further in promoting gender equality and improving our practices as part of a continuous improvement process. ✍️ 🔗 Read our 2024 GEP here: https://lnkd.in/eNSdTh63

🌟 This year marked the new ECRIN strategic plan, established for the 2024-2027 period. 🌟 It was developped by a dedicated ECRIN task force from October 2023 to March 2024, based on the analysis of ECRIN’s position in the environment, and analysis of its strengths, weaknesses, opportunities, and threats. The feedback and suggestions from the ECRIN staff, ECRIN community and the governing body were actively collected during consultations. 💡 This important documents outlines ECRIN’s ambitions for the next four years. The specific actions, timelines and indicators to measure the implementation of these goals will be included in the ECRIN annual workplans. ✍️ 🔗 Read it now: https://lnkd.in/exM_2f8d

To those who celebrate, we would like to wish you a very Merry Christmas!🎄 We hope that all of our connections, far and wide, have a warm, safe and festive break. See you in 2025!☃️❄️

Want to know more about ECRIN National Partners, and their highlights? Read now our National Partners brochure for insights into our 13 member countries. 🤓 We work with national networks of clinical trial units, and with numerous European and international stakeholders involved in clinical research. ECRIN has a national scientific partner in each member country, which are usually networks of clinical trial units (CTUs). This forms a network with over 120 clinical trial units, managing a portfolio of 70 multinational trials spanning an average of 6.3 countries per trial. 💡 ⏩ This brochure outlines their objectives, achievements, and network plans. 🔗 Read the brochure now: https://lnkd.in/gD-V7QZD CZECRIN, Infrastructure F-CRIN, KKS-Netzwerk e. V., HRB National Clinical Trials Office (NCTO), HECRIN (Hungarian National Health Research Agency) GreCRIN _ECRIN, ItaCRIN (Istituto Superiore di Sanità), NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, Spanish Clinical Research Network (SCReN), SLOVACRIN, Swiss Clinical Trial Organisation

🌟 New update on the Regulatory and Ethical Database (#RED): Norway is now available, bringing even more value to the European clinical research community! 🌟 With the inclusion of Norway, RED now provides detailed, up-to-date information on the country’s regulatory and ethical requirements for clinical study submissions. Whether you're planning a new trial or expanding your research into Norway, RED is here to guide you through the process with precision and ease. 😉 Start exploring Norway in RED today and streamline your clinical study submissions! 🔗 Access RED: https://red.ecrin.org/en CZECRIN, Infrastructure F-CRIN, KKS-Netzwerk e. V., HRB National Clinical Trials Office (NCTO), HECRIN (Hungarian National Health Research Agency) GreCRIN _ECRIN, ItaCRIN (Istituto Superiore di Sanità), NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, Spanish Clinical Research Network (SCReN), SLOVACRIN, Swiss Clinical Trial Organisation

Last Friday, ECRIN hosted its 4th CTU Day online. 💻 The event brought together more than 175 members from ECRIN's national partner networks, we shared updates on ECRIN's services and tools. 🔧 Thank you to everyone who was able to join us. You can read the debrief here: https://lnkd.in/eMqjjmNT We look forward to seeing you at next years event. 📆 #ClinicalTrials #CTUDay #EuropeanResearch

✨ Exciting news for developers of innovative therapies! Member State authorities have endorsed the COMBINE programme, a cross-sector initiative designed to streamline combined studies of medicines and medical devices, including diagnostics. The COMBINE programme spans seven cross-sector projects to be rolled out over the coming years, focusing on: ✅ Piloting a single assessment process for multi-country combined studies under device and medicinal product regulations. ✅ Harmonizing serious adverse event reporting processes. ✅ Clarifying the interface between clinical trials and medical device regulations. ✅ Exploring ways to advise sponsors and foster knowledge exchange among national authorities. By fostering collaboration in an inclusive framework, the COMBINE programme brings together competent authorities for clinical trials and medical devices, the European Commission, the European Medicines Agency, ethics committees and key stakeholders like sponsors, clinicians, and patient representatives. 🔗 Learn more about the strategy here: https://lnkd.in/gV8Kya8m #HealthUnion

Over the last two days ECRIN's boards have met to discuss the organisation and the work plan for the coming year. On Tuesday, during our Network Committee meeting the board named Regina Demlova (CZECRIN), as their new chair. Christian Ohmann will remain as acting co-chair as we await the vote for the newly vacant position

Happy holidays to our connections far and wide, on behalf of us all at ECRIN!❄️🎄 We are wishing you all a warm, safe and festive holiday season and are looking forward to many exciting advancements in 2025.☃️